Fair Value Measurement (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
|---|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
10,123 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,123 |
|
|
|
$ |
10,123 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,123 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
11,018 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
11,018 |
|
Commercial paper |
|
|
— |
|
|
|
985 |
|
|
|
— |
|
|
|
985 |
|
|
|
$ |
11,018 |
|
|
$ |
985 |
|
|
$ |
— |
|
|
$ |
12,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
10,672 |
|
|
$ |
— |
|
|
$ |
10,672 |
|
Securities Purchase Agreement Warrants |
|
|
— |
|
|
|
1,917 |
|
|
|
— |
|
|
$ |
1,917 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
265 |
|
|
|
265 |
|
|
|
$ |
— |
|
|
$ |
12,589 |
|
|
$ |
265 |
|
|
$ |
12,854 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
10,114 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,114 |
|
|
|
$ |
10,114 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,114 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
8,840 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
8,840 |
|
Commercial paper |
|
|
— |
|
|
|
1,395 |
|
|
|
— |
|
|
|
1,395 |
|
U.S. government and agency securities |
|
|
— |
|
|
|
1,491 |
|
|
|
— |
|
|
|
1,491 |
|
|
|
$ |
8,840 |
|
|
$ |
2,886 |
|
|
$ |
— |
|
|
$ |
11,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
5,988 |
|
|
$ |
— |
|
|
$ |
5,988 |
|
Contingent earnout liability |
|
|
— |
|
|
|
— |
|
|
|
220 |
|
|
|
220 |
|
|
|
$ |
— |
|
|
$ |
5,988 |
|
|
$ |
220 |
|
|
$ |
6,208 |
|
|
| Summary of Change in Fair Value of Level 3 Financial Instruments |
The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
Contingent
Earnout
Liability |
|
|
Fair value as of December 31, 2023 |
|
|
220 |
|
|
Change in fair value of contingent earnout liability |
|
|
45 |
|
|
Fair value as of March 31, 2024 |
|
$ |
265 |
|
|
|
| Schedule of Cash and Cash Equivalents and Marketable Securities |
The following tables summarize the Company's cash, cash equivalents and available-for-sale securities by significant marketable securities category:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
41,862 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
41,862 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
10,123 |
|
|
|
— |
|
|
|
— |
|
|
|
10,123 |
|
|
|
$ |
51,985 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
51,985 |
|
Marketable Securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
11,018 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
11,018 |
|
Commercial paper |
|
|
986 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
985 |
|
|
|
$ |
12,004 |
|
|
$ |
— |
|
|
$ |
(1 |
) |
|
$ |
12,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
19,030 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
19,030 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
10,114 |
|
|
|
— |
|
|
|
— |
|
|
|
10,114 |
|
|
|
$ |
29,144 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
29,144 |
|
Marketable Securities: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. treasury bills and bonds |
|
$ |
8,838 |
|
|
$ |
2 |
|
|
$ |
— |
|
|
$ |
8,840 |
|
Commercial paper |
|
|
1,395 |
|
|
|
— |
|
|
|
— |
|
|
|
1,395 |
|
U.S. government and agency securities |
|
|
1,492 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
1,491 |
|
|
|
$ |
11,725 |
|
|
$ |
2 |
|
|
$ |
(1 |
) |
|
$ |
11,726 |
|
|
| Amortized Cost and Estimated Fair Value of Marketable Securities |
The following table represents amortized cost and estimated fair value of marketable securities, by contractual maturity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
|
|
|
|
|
Amortized Cost |
|
|
Fair Value |
|
Due in one year or less |
|
|
|
|
|
$ |
12,004 |
|
|
$ |
12,003 |
|
|
| Contingent Earnout Liability |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the contingent earnout liability:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
December 31, |
|
|
|
2024 |
|
|
|
2023 |
|
Fair value of the Company’s Class A common stock |
|
$ |
12.00 |
|
|
|
$ |
7.82 |
|
Risk-free interest rate |
|
|
4.52 |
% |
|
|
|
4.09 |
% |
Expected volatility factor |
|
|
68.8 |
% |
|
|
|
55.0 |
% |
Earnout expiration date |
|
August 16, 2026 |
|
|
|
August 16, 2026 |
|
|
| Credit Agreement Warrants |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the Credit Agreement Warrants:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
December 31, |
|
|
|
2024 |
|
|
|
2023 |
|
Fair value of the Company’s Class A common stock |
$ |
|
12.00 |
|
|
$ |
|
7.82 |
|
Exercise price |
$ |
5.44 - 16.08 |
|
|
$ |
5.44 - 16.08 |
|
Risk-free interest rate |
|
|
4.20 |
% |
|
|
|
3.88 |
% |
Expected volatility factor |
|
|
68.8 |
% |
|
|
|
55.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
|
— |
% |
Remaining contractual term (in years) |
|
8.2 - 9.5 |
|
|
|
8.5 - 9.7 |
|
|
| Securities Purchase Agreement Warrants Member |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the Securities Purchase Agreement Warrants:
|
|
|
|
|
|
|
March 31, |
|
|
|
2024 |
|
Fair value of the Company’s Class A common stock |
$ |
|
12.00 |
|
Exercise price |
$ |
|
14.50 |
|
Risk-free interest rate |
|
|
5.46 |
% |
Expected volatility factor |
|
|
68.8 |
% |
Expected dividend yield |
|
|
— |
% |
Remaining contractual term (in years) |
|
|
0.3 |
|
|